nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100B—peripheral nervous system—Parkinson's disease	0.0682	0.107	CbGeAlD
Olopatadine—S100B—nerve—Parkinson's disease	0.0532	0.0835	CbGeAlD
Olopatadine—S100B—hindbrain—Parkinson's disease	0.0399	0.0625	CbGeAlD
Olopatadine—S100A1—forebrain—Parkinson's disease	0.0255	0.04	CbGeAlD
Olopatadine—S100B—brainstem—Parkinson's disease	0.0228	0.0358	CbGeAlD
Olopatadine—S100B—forebrain—Parkinson's disease	0.022	0.0346	CbGeAlD
Olopatadine—S100A1—cardiovascular system—Parkinson's disease	0.0216	0.0339	CbGeAlD
Olopatadine—S100A13—cardiovascular system—Parkinson's disease	0.0191	0.03	CbGeAlD
Olopatadine—S100A12—cardiovascular system—Parkinson's disease	0.0189	0.0296	CbGeAlD
Olopatadine—S100B—cardiovascular system—Parkinson's disease	0.0186	0.0292	CbGeAlD
Olopatadine—S100A1—medulla oblongata—Parkinson's disease	0.0184	0.0289	CbGeAlD
Olopatadine—S100A1—midbrain—Parkinson's disease	0.0169	0.0264	CbGeAlD
Olopatadine—S100A1—spinal cord—Parkinson's disease	0.0164	0.0258	CbGeAlD
Olopatadine—S100A2—head—Parkinson's disease	0.0159	0.0249	CbGeAlD
Olopatadine—S100A1—head—Parkinson's disease	0.0146	0.0229	CbGeAlD
Olopatadine—S100B—midbrain—Parkinson's disease	0.0146	0.0228	CbGeAlD
Olopatadine—S100B—spinal cord—Parkinson's disease	0.0142	0.0223	CbGeAlD
Olopatadine—S100A1—nervous system—Parkinson's disease	0.0139	0.0217	CbGeAlD
Olopatadine—S100A1—central nervous system—Parkinson's disease	0.0133	0.0209	CbGeAlD
Olopatadine—S100A1—cerebellum—Parkinson's disease	0.013	0.0205	CbGeAlD
Olopatadine—S100A13—head—Parkinson's disease	0.013	0.0203	CbGeAlD
Olopatadine—S100A12—head—Parkinson's disease	0.0128	0.0201	CbGeAlD
Olopatadine—S100B—head—Parkinson's disease	0.0126	0.0198	CbGeAlD
Olopatadine—S100A13—nervous system—Parkinson's disease	0.0123	0.0193	CbGeAlD
Olopatadine—S100B—nervous system—Parkinson's disease	0.012	0.0188	CbGeAlD
Olopatadine—S100A13—central nervous system—Parkinson's disease	0.0118	0.0186	CbGeAlD
Olopatadine—S100A13—cerebellum—Parkinson's disease	0.0116	0.0181	CbGeAlD
Olopatadine—S100B—central nervous system—Parkinson's disease	0.0115	0.0181	CbGeAlD
Olopatadine—S100A2—brain—Parkinson's disease	0.0115	0.018	CbGeAlD
Olopatadine—S100B—cerebellum—Parkinson's disease	0.0113	0.0177	CbGeAlD
Olopatadine—S100A1—brain—Parkinson's disease	0.0106	0.0166	CbGeAlD
Olopatadine—S100A13—brain—Parkinson's disease	0.00939	0.0147	CbGeAlD
Olopatadine—S100A12—brain—Parkinson's disease	0.00927	0.0145	CbGeAlD
Olopatadine—S100B—brain—Parkinson's disease	0.00915	0.0144	CbGeAlD
Olopatadine—HRH1—forebrain—Parkinson's disease	0.00452	0.00709	CbGeAlD
Olopatadine—HRH1—head—Parkinson's disease	0.00259	0.00406	CbGeAlD
Olopatadine—HRH1—nervous system—Parkinson's disease	0.00245	0.00385	CbGeAlD
Olopatadine—HRH1—central nervous system—Parkinson's disease	0.00236	0.00371	CbGeAlD
Olopatadine—Clomipramine—GSTP1—Parkinson's disease	0.00222	0.0436	CrCbGaD
Olopatadine—Acepromazine—DRD1—Parkinson's disease	0.00221	0.0433	CrCbGaD
Olopatadine—Thiothixene—DRD1—Parkinson's disease	0.00212	0.0417	CrCbGaD
Olopatadine—CYP3A4—nervous system—Parkinson's disease	0.0019	0.00298	CbGeAlD
Olopatadine—HRH1—brain—Parkinson's disease	0.00188	0.00294	CbGeAlD
Olopatadine—Acepromazine—HTR1A—Parkinson's disease	0.00183	0.036	CrCbGaD
Olopatadine—CYP3A4—central nervous system—Parkinson's disease	0.00183	0.00287	CbGeAlD
Olopatadine—Thiothixene—HTR1A—Parkinson's disease	0.00176	0.0346	CrCbGaD
Olopatadine—Cyclobenzaprine—HTR2A—Parkinson's disease	0.00174	0.0341	CrCbGaD
Olopatadine—Chlorprothixene—DRD3—Parkinson's disease	0.0017	0.0334	CrCbGaD
Olopatadine—Chlorprothixene—DRD1—Parkinson's disease	0.00167	0.0328	CrCbGaD
Olopatadine—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.00159	0.0312	CrCbGaD
Olopatadine—Acepromazine—DRD2—Parkinson's disease	0.00156	0.0305	CrCbGaD
Olopatadine—Thiothixene—DRD2—Parkinson's disease	0.0015	0.0294	CrCbGaD
Olopatadine—Nortriptyline—HTR1A—Parkinson's disease	0.00136	0.0267	CrCbGaD
Olopatadine—Imipramine—HTR7—Parkinson's disease	0.00124	0.0243	CrCbGaD
Olopatadine—Amitriptyline—HTR7—Parkinson's disease	0.00123	0.0242	CrCbGaD
Olopatadine—Doxepin—HTR1A—Parkinson's disease	0.00122	0.024	CrCbGaD
Olopatadine—Acepromazine—HTR2A—Parkinson's disease	0.0012	0.0236	CrCbGaD
Olopatadine—Chlorprothixene—DRD2—Parkinson's disease	0.00118	0.0231	CrCbGaD
Olopatadine—Amitriptyline—DRD3—Parkinson's disease	0.00116	0.0227	CrCbGaD
Olopatadine—Thiothixene—HTR2A—Parkinson's disease	0.00116	0.0227	CrCbGaD
Olopatadine—Nortriptyline—DRD2—Parkinson's disease	0.00116	0.0227	CrCbGaD
Olopatadine—Nortriptyline—CYP2E1—Parkinson's disease	0.00111	0.0218	CrCbGaD
Olopatadine—Imipramine—SLC6A3—Parkinson's disease	0.00108	0.0213	CrCbGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Parkinson's disease	0.00108	0.00348	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.00108	0.00348	CbGpPWpGaD
Olopatadine—Thiothixene—CYP2D6—Parkinson's disease	0.00106	0.0208	CrCbGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—Parkinson's disease	0.00104	0.00333	CbGpPWpGaD
Olopatadine—Doxepin—DRD2—Parkinson's disease	0.00104	0.0204	CrCbGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Parkinson's disease	0.00103	0.0033	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.00102	0.00329	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—Parkinson's disease	0.00101	0.00324	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000981	0.00315	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	0.000974	0.00312	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Parkinson's disease	0.000972	0.00312	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.000961	0.00308	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GPR37—Parkinson's disease	0.00096	0.00308	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DGKQ—Parkinson's disease	0.00096	0.00308	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000957	0.00307	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—Parkinson's disease	0.000954	0.00306	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—ADRBK1—Parkinson's disease	0.000952	0.00305	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000952	0.00305	CbGpPWpGaD
Olopatadine—Imipramine—HTR1A—Parkinson's disease	0.00095	0.0187	CrCbGaD
Olopatadine—Amitriptyline—HTR1A—Parkinson's disease	0.000944	0.0185	CrCbGaD
Olopatadine—S100A12—Immune System—DCTN1—Parkinson's disease	0.000926	0.00297	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	0.000921	0.00295	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—Parkinson's disease	0.000918	0.00295	CbGpPWpGaD
Olopatadine—Clomipramine—HTR2A—Parkinson's disease	0.000913	0.0179	CrCbGaD
Olopatadine—Chlorprothixene—HTR2A—Parkinson's disease	0.000909	0.0179	CrCbGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000905	0.0029	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—ADRBK1—Parkinson's disease	0.0009	0.00289	CbGpPWpGaD
Olopatadine—Nortriptyline—HTR2A—Parkinson's disease	0.000893	0.0175	CrCbGaD
Olopatadine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.000885	0.00284	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000878	0.00282	CbGpPWpGaD
Olopatadine—S100B—Immune System—DCTN1—Parkinson's disease	0.000875	0.00281	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—IL6—Parkinson's disease	0.000868	0.00279	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00086	0.00276	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DRA—Parkinson's disease	0.000842	0.0027	CbGpPWpGaD
Olopatadine—Clomipramine—CYP2D6—Parkinson's disease	0.000835	0.0164	CrCbGaD
Olopatadine—S100A12—Immune System—PLA2G6—Parkinson's disease	0.000833	0.00267	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—Parkinson's disease	0.000826	0.00265	CbGpPWpGaD
Olopatadine—Nortriptyline—CYP2D6—Parkinson's disease	0.000816	0.016	CrCbGaD
Olopatadine—Imipramine—DRD2—Parkinson's disease	0.000807	0.0158	CrCbGaD
Olopatadine—Amitriptyline—DRD2—Parkinson's disease	0.000802	0.0157	CrCbGaD
Olopatadine—Doxepin—HTR2A—Parkinson's disease	0.000801	0.0157	CrCbGaD
Olopatadine—S100B—Immune System—HLA-DRA—Parkinson's disease	0.000796	0.00255	CbGpPWpGaD
Olopatadine—S100B—Immune System—PLA2G6—Parkinson's disease	0.000788	0.00253	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—IL6—Parkinson's disease	0.000781	0.00251	CbGpPWpGaD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00078	0.0025	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.000777	0.00249	CbGpPWpGaD
Olopatadine—Imipramine—CYP2E1—Parkinson's disease	0.000776	0.0152	CrCbGaD
Olopatadine—S100A12—Innate Immune System—ABL1—Parkinson's disease	0.000776	0.00249	CbGpPWpGaD
Olopatadine—Amitriptyline—CYP2E1—Parkinson's disease	0.000771	0.0152	CrCbGaD
Olopatadine—S100B—Signaling Pathways—RIT2—Parkinson's disease	0.000768	0.00246	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PARK2—Parkinson's disease	0.000761	0.00244	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FGF20—Parkinson's disease	0.000755	0.00242	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000749	0.0024	CbGpPWpGaD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000747	0.0024	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000743	0.00238	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.000735	0.00236	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—ABL1—Parkinson's disease	0.000734	0.00235	CbGpPWpGaD
Olopatadine—Doxepin—CYP2D6—Parkinson's disease	0.000732	0.0144	CrCbGaD
Olopatadine—S100B—Signaling Pathways—GRK5—Parkinson's disease	0.000728	0.00233	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00072	0.00231	CbGpPWpGaD
Olopatadine—S100B—Immune System—PARK2—Parkinson's disease	0.000719	0.00231	CbGpPWpGaD
Olopatadine—S100B—Immune System—FGF20—Parkinson's disease	0.000714	0.00229	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.000698	0.00224	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000692	0.00222	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000685	0.0022	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00066	0.00212	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000654	0.0021	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GRM4—Parkinson's disease	0.000653	0.00209	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000652	0.00209	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000632	0.00203	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.000625	0.002	CbGpPWpGaD
Olopatadine—Imipramine—HTR2A—Parkinson's disease	0.000623	0.0122	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—Parkinson's disease	0.000619	0.0122	CrCbGaD
Olopatadine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.000619	0.00199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PENK—Parkinson's disease	0.000619	0.00199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAG—Parkinson's disease	0.000619	0.00199	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—Parkinson's disease	0.000616	0.00198	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000604	0.00194	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.000601	0.00193	CbGpPWpGaD
Olopatadine—Clomipramine—ABCB1—Parkinson's disease	0.000596	0.0117	CrCbGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000596	0.00191	CbGpPWpGaD
Olopatadine—Chlorprothixene—ABCB1—Parkinson's disease	0.000594	0.0117	CrCbGaD
Olopatadine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.00057	0.00183	CbGpPWpGaD
Olopatadine—Imipramine—CYP2D6—Parkinson's disease	0.00057	0.0112	CrCbGaD
Olopatadine—Amitriptyline—CYP2D6—Parkinson's disease	0.000566	0.0111	CrCbGaD
Olopatadine—S100B—Signaling Pathways—PDYN—Parkinson's disease	0.000566	0.00182	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ADRBK1—Parkinson's disease	0.000555	0.00178	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.000554	0.00178	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000548	0.00176	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000541	0.00174	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000535	0.00172	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GFAP—Parkinson's disease	0.000532	0.00171	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000529	0.0017	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GRM5—Parkinson's disease	0.000526	0.00169	CbGpPWpGaD
Olopatadine—S100B—Immune System—ADRBK1—Parkinson's disease	0.000524	0.00168	CbGpPWpGaD
Olopatadine—Doxepin—ABCB1—Parkinson's disease	0.000523	0.0103	CrCbGaD
Olopatadine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.000521	0.00167	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000513	0.00164	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.0005	0.0016	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00049	0.00157	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.000485	0.00155	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00048	0.00154	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00047	0.00151	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000464	0.00149	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000464	0.00149	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000462	0.00148	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGF20—Parkinson's disease	0.000461	0.00148	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000454	0.00146	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	0.000454	0.00146	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000454	0.00145	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ABL1—Parkinson's disease	0.000452	0.00145	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000447	0.00144	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000439	0.00141	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000429	0.00138	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000429	0.00138	CbGpPWpGaD
Olopatadine—S100B—Immune System—ABL1—Parkinson's disease	0.000427	0.00137	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HGF—Parkinson's disease	0.000425	0.00136	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000423	0.00136	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00042	0.00135	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000415	0.00133	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INSR—Parkinson's disease	0.000413	0.00132	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000412	0.00132	CbGpPWpGaD
Olopatadine—Imipramine—ABCB1—Parkinson's disease	0.000407	0.00799	CrCbGaD
Olopatadine—Amitriptyline—ABCB1—Parkinson's disease	0.000404	0.00794	CrCbGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000403	0.00129	CbGpPWpGaD
Olopatadine—S100B—Immune System—HGF—Parkinson's disease	0.000402	0.00129	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000397	0.00127	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000397	0.00127	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGB—Parkinson's disease	0.00039	0.00125	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR1A—Parkinson's disease	0.000388	0.00125	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000383	0.00123	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TAC1—Parkinson's disease	0.000382	0.00123	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000379	0.00122	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.000376	0.00121	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DRD1—Parkinson's disease	0.000375	0.0012	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DRD3—Parkinson's disease	0.000363	0.00116	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000358	0.00115	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.000352	0.00113	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK8—Parkinson's disease	0.000351	0.00113	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.000345	0.00111	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.000344	0.0011	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00034	0.00109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000339	0.00109	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.000334	0.00107	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK8—Parkinson's disease	0.000332	0.00106	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DRD2—Parkinson's disease	0.000328	0.00105	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR7—Parkinson's disease	0.000328	0.00105	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000325	0.00104	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.000324	0.00104	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.000322	0.00103	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000318	0.00102	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	0.000309	0.00099	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	0.000302	0.00097	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	0.000302	0.00097	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000295	0.000945	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	0.000293	0.000938	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000284	0.000912	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000281	0.0009	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000278	0.000893	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF2—Parkinson's disease	0.000275	0.000883	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000274	0.000879	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	0.000268	0.00086	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	0.000268	0.00086	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	0.000268	0.000858	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1R—Parkinson's disease	0.000266	0.000853	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EDN1—Parkinson's disease	0.000263	0.000843	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00026	0.000834	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000257	0.000823	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	0.000249	0.000798	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000245	0.000787	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	0.000242	0.000777	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGF—Parkinson's disease	0.000242	0.000775	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000233	0.000747	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2A—Parkinson's disease	0.00023	0.000738	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—Parkinson's disease	0.000224	0.000719	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—Parkinson's disease	0.000223	0.000715	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000216	0.000691	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000215	0.000688	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	0.000214	0.000688	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000214	0.000687	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—Parkinson's disease	0.000214	0.000686	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000213	0.000682	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—Parkinson's disease	0.000212	0.00068	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000212	0.00068	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000212	0.000679	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000212	0.000679	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—Parkinson's disease	0.000211	0.000676	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK8—Parkinson's disease	0.000204	0.000656	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	0.000203	0.000652	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000202	0.000648	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000199	0.000638	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000197	0.000632	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000195	0.000626	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000194	0.000624	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK8—Parkinson's disease	0.000193	0.00062	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000189	0.000606	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000184	0.000589	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INS—Parkinson's disease	0.000183	0.000586	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	0.000182	0.000585	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	0.000181	0.00058	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	0.000177	0.000569	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000177	0.000566	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PENK—Parkinson's disease	0.000173	0.000554	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAG—Parkinson's disease	0.000173	0.000554	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	0.000172	0.000551	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000171	0.000548	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000171	0.000548	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00016	0.000514	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	0.000158	0.000507	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	0.000155	0.000498	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	0.000155	0.000498	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	0.000149	0.000477	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	0.000147	0.000471	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.00014	0.000448	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ND3—Parkinson's disease	0.00014	0.000448	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000137	0.000439	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—Parkinson's disease	0.000136	0.000436	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000131	0.000422	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000131	0.000422	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—Parkinson's disease	0.000131	0.000419	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00013	0.000418	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	0.000129	0.000413	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK8—Parkinson's disease	0.000125	0.000401	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000125	0.000401	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000125	0.0004	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	0.000124	0.000399	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—Parkinson's disease	0.000123	0.000396	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00012	0.000384	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000119	0.000381	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INSR—Parkinson's disease	0.000115	0.00037	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGB—Parkinson's disease	0.000109	0.00035	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000109	0.000349	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	0.000108	0.000348	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	0.000107	0.000343	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000106	0.00034	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000106	0.00034	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000106	0.00034	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	0.000105	0.000336	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	0.000101	0.000325	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	9.47e-05	0.000304	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	9.17e-05	0.000294	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	9.17e-05	0.000294	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—Parkinson's disease	7.98e-05	0.000256	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DDC—Parkinson's disease	7.77e-05	0.000249	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	7.68e-05	0.000247	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	7.43e-05	0.000238	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	7.34e-05	0.000236	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	7.34e-05	0.000236	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGF—Parkinson's disease	6.75e-05	0.000216	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	6.61e-05	0.000212	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MAOB—Parkinson's disease	6.54e-05	0.00021	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	6.42e-05	0.000206	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—Parkinson's disease	5.97e-05	0.000192	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INS—Parkinson's disease	5.1e-05	0.000164	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.86e-05	0.000156	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.77e-05	0.000153	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.45e-05	0.000143	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.4e-05	0.000141	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TH—Parkinson's disease	4.34e-05	0.000139	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.16e-05	0.000134	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	3.8e-05	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	3.77e-05	0.000121	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COMT—Parkinson's disease	3.69e-05	0.000118	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.67e-05	0.000118	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.66e-05	0.000117	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.62e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	3.49e-05	0.000112	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.47e-05	0.000111	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.37e-05	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.23e-05	0.000104	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.98e-05	9.56e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—Parkinson's disease	2.77e-05	8.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INS—Parkinson's disease	2.37e-05	7.6e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—Parkinson's disease	2.23e-05	7.15e-05	CbGpPWpGaD
